Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongguan Capsule for Prevention of Ventricular Remodeling After Myocardial Infarction
ChiCTR-IPR-17011618Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2017
- Countries
- 1
01
Overview
Phase 4 trial of Tongguan Jiaonang in myocardial infarction (MI) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Left ventricular end-diastolic volume. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
Tongguan Jiaonang
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-IPR-17011618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011618.